Valuation: Proteome Sciences plc

Market Cap 5.79M 7.73M 6.76M 6.21M 10.97M 736M 11.16M 74.72M 28.96M 361M 29.04M 28.41M 1.24B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 20.78M 27.76M 24.26M 22.28M 39.39M 2.64B 40.05M 268M 104M 1.3B 104M 102M 4.47B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.91%
Yield 2024 *
-
Yield 2025 -
1 day+16.59%
1 week+12.17%
Current month+16.59%
1 month+20.23%
3 months+21.75%
6 months-28.75%
Current year-23.05%
1 week 1.3
Extreme 1.3
2.3
1 month 1.3
Extreme 1.3
2.3
Current year 1.2
Extreme 1.2
4.4
1 year 1.2
Extreme 1.2
4.4
3 years 1.2
Extreme 1.2
8.71
5 years 1.2
Extreme 1.2
8.79
10 years 1.2
Extreme 1.2
20.25
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 62 01/01/2010
Director/Board Member 71 01/07/2014
Date Insider Type Main position Quantity % Market Cap.
14/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
14/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
06/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
+16.59%+12.17%-36.72%-75.26% 7.73M
+3.49%+2.32%-28.86%-12.49% 166B
+5.04%+3.32%-5.77%-5.57% 106B
+2.80%+3.33%+1.83%+54.09% 57.69B
+1.33%+1.39%+53.16%+49.84% 53.2B
+3.39%+4.43%-10.83%-40.12% 43.56B
+3.50%+14.35% - - 36.52B
+3.47%+3.79%-14.75%-44.56% 27.49B
+0.20%+5.53%+65.33%-4.37% 25.84B
+2.78%+3.61%-8.42%-3.01% 21.27B
Average +4.26%+3.49%+1.66%-9.05% 53.82B
Weighted average by Cap. +3.31%+3.29%-3.68%-0.10%

Financials

2024 2025
Net sales 4.89M 6.53M 5.71M 5.24M 9.26M 622M 9.42M 63.1M 24.45M 305M 24.52M 23.99M 1.05B 3.76M 5.02M 4.39M 4.03M 7.12M 478M 7.24M 48.49M 18.79M 234M 18.85M 18.44M 808M
Net income -3.41M -4.55M -3.98M -3.65M -6.46M -433M -6.57M -43.97M -17.04M -213M -17.09M -16.72M -732M -3.06M -4.09M -3.57M -3.28M -5.8M -389M -5.9M -39.52M -15.32M -191M -15.36M -15.03M -658M
Net Debt 13.39M 17.9M 15.64M 14.36M 25.39M 1.7B 25.82M 173M 67.02M 836M 67.21M 65.75M 2.88B 14.99M 20.03M 17.5M 16.07M 28.42M 1.91B 28.9M 194M 75M 935M 75.21M 73.58M 3.22B
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
03/07/26 GBX 1.924 +16.59% 118,863
02/07/26 GBX 1.650 0.00% 2
01/07/26 GBX 1.650 0.00% 29,546
30/06/26 GBX 1.650 -8.33% 54,141
29/06/26 GBX 1.800 +4.96% 486,345